Related Experiment Video
Updated: Aug 17, 2026

Measuring Skeletal Muscle Thermogenesis in Mice and Rats
Published on: July 27, 2022
Effects of 3,4-methylenedioxymethamphetamine and related amphetamines on autonomic and behavioral thermoregulation
Emily J Jaehne1, Abdallah Salem, Rodney J Irvine
1Department of Clinical and Experimental Pharmacology, University of Adelaide, Adelaide, South Australia, 5005, Australia.
Abstract:
3,4-Methylenedioxymethamphetamine (MDMA, 'ecstasy') and related amphetamines such as para-methoxyamphetamine (PMA) disrupt normal thermoregulation in humans and rats. Behavior, an important component of thermoregulation in mammals, has not been investigated with respect to these drugs. This is surprising as harm minimization depends on appropriate thermoregulatory behavior by drug users. The effects of MDMA (10 mg/kg), PMA (10 mg/kg) and d-amphetamine (2 mg/kg) were therefore studied in Sprague-Dawley rats, with telemetry implants measuring core body temperature (T(C)), locomotor activity and heart rate. Rats were administered an amphetamine or saline and confined to an ambient temperature of 21, 30 or 15 degrees C for 30 min, before being able to choose their preferred temperature (T(P)) on a thermally graded runway (11-41 degrees C). Confinement at 21 degrees C had little effect on T(C) in any group. At 30 degrees C MDMA and PMA increased T(C) compared to saline (p<0.001). MDMA treated animals behaviorally overcompensated for this effect (p<0.01). Locomotor activity after MDMA treatment was significantly elevated compared with saline (p<0.01). In contrast, at 15 degrees C MDMA administration resulted in a lower T(C) than saline (p<0.001). MDMA and PMA disrupt autonomic components of thermoregulation, while behavioral components are disrupted to a lesser extent. These results highlight differences in thermoregulatory responses to individual drugs, which were only evident when behavior was measured, and this may be important in assessing their risk.
More Related Videos
09:16A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
04:54Using a Combination of Indirect Calorimetry, Infrared Thermography, and Blood Glucose Levels to Measure Brown Adipose Tissue Thermogenesis in Humans
Published on: June 2, 2023
Related Concept Videos
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Body Temperature
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Factors Affecting Body Temperature
Factors may include:
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...